Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.
about
Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interfaceAdvances in HIV microbicide developmentNon-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex WorkersNew approaches to making the microenvironment of the female reproductive tract hostile to HIV.Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesMolecular definition of vaginal microbiota in East African commercial sex workers.Mucosal correlates of protection in HIV-1-exposed sero-negative persons.Innate immunity against HIV: a priority target for HIV prevention researchTrappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CUse of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsGenetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of EntryAnti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsMolecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells.A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.Dissecting the HIV-specific immune response: a systems biology approach.HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genesAntiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collectionHost proteome research in HIV infection.Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells.Immune quiescence: a model of protection against HIV infection.Role of the innate immunity in female reproductive tract.High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals.Immune correlates of HIV exposure without infection in foreskins of men from Rakai, UgandaSecretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Probiotic strategies for the treatment and prevention of bacterial vaginosis.HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
P2860
Q21245044-37BBDEAA-568A-4853-8AC1-6960F3ED6416Q26852858-73626514-74D5-4B2B-B8AF-40BEAE89E529Q28548507-97496CD5-1D22-4BD9-9820-AA4FAC176B53Q30398454-0A8FAC9F-0C22-4C72-B043-01079F250E33Q33627673-2F504472-F953-4BE1-A976-47E5E95915E1Q33885531-4B0208DF-CEE8-4119-B2ED-3D13AD817A05Q33911540-40410C06-3B23-4E45-8707-DF34F9296768Q34243462-BEBD5029-EA89-408B-BBE2-E4F0F5228650Q34251265-252183B8-3602-4848-9F20-6803F27457A7Q34467932-6AF1B40C-ED1A-4A51-B60D-B40DAC194195Q34541093-7869BB37-CE43-4830-ABCE-ED76485A5DE8Q34680240-63A16949-7840-492A-8F84-9242309ABEAAQ34712244-E15CB49D-F925-4036-A1F2-4B6DDAC9C2ACQ35030053-A1FBA2E1-566D-4443-8C7D-00AA33D1F35FQ35092851-ED9F3CC7-B654-447D-8E5E-20AB178412B3Q35852782-586870E2-4BCB-4F46-A5ED-3363E6B416EEQ35868058-1C069419-9D28-424A-9353-5CFF3E62F96DQ35913894-5E865BA4-3118-4734-9070-49464ED70F86Q36111516-82611968-E1BE-4660-98E8-1AD38B5D86C5Q36135690-362C6F37-3382-45ED-B5CB-99BCC3D95593Q36358905-DD7619A2-E327-486D-8411-7F7DDD8448BCQ36363258-F42CBF2F-4581-48CC-982D-553681860471Q36750287-6783D11C-2E17-462A-8821-6CC883DFED51Q36759980-D9CD320F-7D78-4763-874D-F2BB810B6E68Q36769115-BBBA16C0-E2CE-405A-B614-934B23152885Q36892927-E49C6C01-23A1-43FB-BDF6-70E0E916E0E4Q36978882-658926D3-3484-46F4-9207-B273912AED7CQ37309287-E7046593-75AD-49B8-AC3F-4D5D3CB76ED0Q37318371-AEA4C24D-109A-4CA6-BE7C-D2CD3BFB1932Q37334286-51410869-13F2-48E7-A676-200234EFB70EQ37334315-E846A327-EF73-4217-8D84-13D10C499CA7Q37418185-12370B79-3D12-4F2A-8453-59475478EC5FQ37592611-42696F33-DB9E-409B-882A-7C76B642165CQ37637890-2A862105-22C3-4343-B94E-6515FD5FC423Q37720097-CF898CEB-9D76-4E6A-A801-7BA429F1A2B7Q37731798-BE1C92C4-1377-45E7-AC8F-67DC73431C0EQ37809873-91E14F97-9329-4846-AB96-8FE907F75E8CQ37827574-3D12905C-E8A7-415C-A321-C37A6C71FE9AQ37854081-6E11F685-D2A0-4F6F-93AB-398BC1282FB7Q37936538-10112BC5-2D10-4373-84DF-421F322C69E5
P2860
Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@ast
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@en
type
label
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@ast
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@en
prefLabel
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@ast
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@en
P2093
P50
P1433
P1476
Elevated elafin/trappin-2 in t ...... ction against HIV acquisition.
@en
P2093
Brian J Pak
Lillian Maranan
Pauline Levinson
Shehzad M Iqbal
Terry B Ball
Vladimir N Podust
Walter Jaoko
P304
P356
10.1097/QAD.0B013E32832EA643
P407
P577
2009-08-01T00:00:00Z